Welcome to our dedicated page for Equifax SEC filings (Ticker: EFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Equifax’s credit files touch nearly every U.S. consumer, and that reach makes its SEC disclosures uniquely data-dense. The annual 10-K doesn’t just report revenue; it details cybersecurity investments, Equifax Cloud migration milestones, and how Workforce Solutions monetizes real-time income data. Whether you’re tracking credit-report volume, breach-related legal accruals, or global segment trends, this page gathers every document in one place and keeps it current.
Looking for the Equifax annual report 10-K simplified, the latest Equifax quarterly earnings report 10-Q filing, or an Equifax 8-K material events explained alert? They’re here alongside Equifax proxy statement executive compensation materials and each Equifax insider trading Form 4 transactions notice. Stock Titan’s AI reads the footnotes so you don’t have to, producing plain-English briefs that answer natural queries like “What are Equifax’s cyber spend trends?” or “How did Workforce Solutions margin move this quarter?” Our platform also streams Equifax Form 4 insider transactions real-time, highlighting officer buys and sells minutes after they hit EDGAR.
Use the summaries to compare fraud-loss reserves between periods, spot patterns in Equifax executive stock transactions Form 4, or dive into our Equifax earnings report filing analysis for revenue-per-file metrics. From risk factors to segment tables, you’ll find Equifax SEC filings explained simply; it’s all about understanding Equifax SEC documents with AI—faster, clearer, and always up to date.
The Vanguard Group filed Amendment No. 14 to Schedule 13G reporting a passive beneficial ownership stake in Equifax Inc. (EFX). Vanguard reported 15,282,951 shares beneficially owned, representing 12.34% of the class as of 09/30/2025.
Vanguard reported 0 shares with sole voting power and 731,561 shares with shared voting power. It disclosed 14,103,287 shares with sole dispositive power and 1,179,664 shares with shared dispositive power. Vanguard certified the securities were acquired and held in the ordinary course and not for the purpose of changing or influencing control. Vanguard noted its clients have the right to receive dividends or proceeds, and no one other person's interest exceeds 5%.
Equifax (EFX) CEO and director reported insider transactions on 10/27/2025. The reporting person exercised 27,959 stock options at $191.44 and executed multiple open‑market sales under a Rule 10b5‑1 trading plan adopted on 11/14/2024, plus a G code gift of 47 shares.
Sales included 6,943 shares at a weighted average price of $232.1887 and 6,639 shares at $230.184, among other tranches disclosed. Following the reported transactions, direct beneficial ownership was 142,934 shares. Indirect holdings in grantor retained annuity trusts (GRATs) remained, including 22,045 shares in the “2‑yr Jun 2025 GRAT” and 16,287 shares in the “3‑yr Jul 2024 GRAT.”
Equifax (EFX) reported an insider transaction by its EVP, Chief Technology Officer. On 10/27/2025, the officer exercised options for 4,925 shares of common stock at $175.48 per share (code M) and sold 4,925 shares at $238.94 (code S) pursuant to a Rule 10b5-1 trading plan adopted on 4/25/2025.
Following these transactions, the officer directly beneficially owned 39,364 shares. The option related to 4,925 underlying shares had an exercise price of $175.48 and an expiration of 02/21/2026, and vested in three equal annual increments beginning 2/21/2021. Holdings include accrued dividend equivalent units and shares acquired via the company’s 2020 Employee Stock Purchase Plan.
Equifax Inc. filed a Form 144 notice for a proposed sale of 49,345 common shares. The filing lists Fidelity Brokerage Services as broker and an aggregate market value of $11,404,110.96, with an approximate sale date of 10/27/2025 on the NYSE.
The shares to be sold reflect prior acquisitions: 21,386 shares from restricted stock vesting on 05/04/2021 (compensation) and 27,959 shares tied to an option granted on 02/21/2020, with cash payment dated 10/27/2025. Shares outstanding were 122,394,037; this is a baseline figure, not the amount being sold.
The filing also notes a sale during the prior three months: Mark W. Begor sold 48,264 common shares on 07/28/2025 for gross proceeds of $11,666,012.59.
Form 144 notice filed for a proposed sale of 4,925 common shares. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 10/27/2025. The filing lists an aggregate market value of $1,176,779.50 for the proposed sale.
The seller acquired 4,925 shares on 10/27/2025 via an option originally granted on 02/21/2020, with payment noted as cash. The filing also cites 122,394,037 shares outstanding; this is a baseline figure, not the amount being offered.
Equifax Inc. reported Q3 2025 results with operating revenue of $1,544.9 million, up 7% year over year, and operating income of $264.3 million. Diluted EPS was $1.29 versus $1.13 a year ago as segment growth offset higher SG&A and depreciation. Interest expense declined to $52.2 million.
Growth was broad-based: Workforce Solutions revenue rose to $649.4 million (+5%), U.S. Information Solutions to $530.2 million (+11%), and International to $365.3 million (+6%). Year to date, cash provided by operating activities was $1,144.9 million with capital expenditures of $349.1 million. The company repurchased $300.0 million of shares in Q3 (1.24 million shares) and paid a quarterly dividend of $0.50 per share. Total debt was $4,835.6 million with $1.4 billion available under the Revolver at September 30, 2025.
Equifax Inc. (EFX) furnished its quarterly results press release for the three months ended September 30, 2025. The company issued the release on October 21, 2025, and attached it as Exhibit 99.1. The press release is being furnished and is not deemed filed for purposes of Section 18 of the Exchange Act, nor incorporated by reference into Securities Act filings unless specifically referenced.
Director Marcus Robert D. reported on Form 4 that on 09/30/2025 he was issued 132 phantom stock units under Equifax Inc.'s deferred compensation plan in lieu of his annual cash retainer. Each phantom unit is the economic equivalent of one share of common stock and is valued in the filing at $256.53 per share. Following the award, the reporting person beneficially owns 2,127 shares directly. The filing states the phantom units become payable, at the director's election, upon termination of his board service.
Form 144 notice by an Equifax insider to sell common stock. The filer intends to sell 4,553 shares of Equifax common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value reported as $1,111,895.40 and total shares outstanding listed as 123,797,380. The securities to be sold derive from stock options granted on 11/01/2019 (722 shares) and 09/28/2018 (3,831 shares); payment is shown as cash and the approximate date of sale is 08/29/2025. The filing indicates no securities were sold by the reporting person in the past three months and includes the standard representation that the seller knows of no undisclosed material adverse information about the issuer.
Form 144 notice for Equifax, Inc. (EFX) reporting a proposed sale of 3,764 common shares with an aggregate market value of $964,649.84 to be sold on 08/22/2025 through Fidelity Brokerage Services LLC on the NYSE. The filing lists acquisition details for these shares as an option granted on 02/09/2024 with an acquisition date recorded as 08/22/2025 and payment in cash. An additional 1 share was acquired via dividend reinvestment on 06/12/2025. The filing also discloses a sale by Todd M. Horvath of 8,797 common shares on 08/20/2025 yielding $2,199,425.94. The notice includes the required representation that the seller does not possess undisclosed material adverse information about the issuer.
FAQ
What is the current stock price of Equifax (EFX)?
What is the market cap of Equifax (EFX)?
